MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Song, Yong Xi ^a   Yue, Zhen Yu ^a   Wang, Zhen Ning ^a   Xu, Ying Ying ^a   Luo, Yang ^a   Xu, Hui Mian ^a   Zhang, Xue ^a   Jiang, Li ^a   Xing, Cheng Zhong ^a   Zhang, Yong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; LUCIFERASE; MICRORNA; MICRORNA 148B; UNCLASSIFIED DRUG; MIRN148 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CASE CONTROL STUDY; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; REPORTER GENE; STOMACH TUMOR; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; RECEPTOR, CHOLECYSTOKININ B; STOMACH NEOPLASMS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 78650762564     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-1     Document Type: Article

References (53)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12:354-362.
2. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524. 10.1126/science.1111444, 16141061.
3. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006, 15:R17-29. 10.1093/hmg/ddl046, 16651366.
4. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004. 10.1073/pnas.0307323101, 365734, 14973191.
5. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorig-enesis. Br J Cancer 2006, 94:776-780. 10.1038/sj.bjc.6603023, 2361377, 16495913.
6. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
7. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
8. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 2010, 9:16. 10.1186/1476-4598-9-16, 2835654, 20102618.
9. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T, Vassella E. MiR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 2009, 69:5553-5559. 10.1158/0008-5472.CAN-08-4277, 19549910.
10. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncoge-nic activities. Nat Med 2008, 14:1271-1277. 10.1038/nm.1880, 18931683.
11. Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009, 69:4851-4860.
12. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009, 69:1135-1142. 10.1158/0008-5472.CAN-08-2886, 19155302.
13. Foley NH, Bray IM, Tivnan A, Bryan K, Murphy DM, Buckley PG, Ryan J, O'Meara A, O'Sullivan M, Stallings RL. MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol Cancer 2010, 9:83. 10.1186/1476-4598-9-83, 2864218, 20409325.
14. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, Liu Z. Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance. J Gastrointest Surg 2010, 14:1170-1179. 10.1007/s11605-010-1202-2, 20422307.
15. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, Wen YM, Wang CM, Yi XZ. The expression profile of microRNAs in a model of 7,12-dimethyl-benz [a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009, 28:64-74. 10.1186/1756-9966-28-64, 2687417, 19435529.
16. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908. 10.1001/jama.297.17.1901, 17473300.
17. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436. 10.1001/jama.299.4.425, 2614237, 18230780.
18. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010, 11:136-146. 10.1016/S1470-2045(09)70343-2, 20022810.
19. Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force Aldred S, Fedorov Y. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS One 2009, 4:e5605. 10.1371/journal.pone.0005605, 2680014, 19440384.
20. Castelli EC, Moreau P, Oya e Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L, Giuliatti S, Carosella ED, Donadi EA. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009, 70:1020-1025. 10.1016/j.humimm.2009.07.028, 19664672.
21. Zhao Y, Jia HL, Zhou HJ, Dong QZ, Fu LY, Yan ZW, Sun J, Ren N, Ye QH, Qin LX. Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR. Zhonghua Gan Zang Bing Za Zhi 2009, 17:526-530.
22. Duursma AM, Kedde M, Schrier M, Le Sage C, Agami R. MiR-148 targets human DNMT3b protein coding region. RNA 2008, 14:872-877. 10.1261/rna.972008, 2327368, 18367714.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
24. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773. 10.1038/nature03315, 15685193.
25. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. 10.1016/S0092-8674(03)01018-3, 14697198.
27. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. MiR-Base: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-144. 10.1093/nar/gkj112, 1347474, 16381832.
28. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4:70-77.
29. Liang RQ, Li W, Li Y, Tan CY, Li JX, Jin YX, Ruan KC. An oligo nucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe. Nucleic Acids Res 2005, 33:e17. 10.1093/nar/gni019, 548377, 15684409.
30. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. 10.1038/nature03702, 15944708.
31. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, Su H, Zhuang SM. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008, 29:2126-2131. 10.1093/carcin/bgn195, 18711148.
32. Shi R, Chiang VL. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 2005, 39:519-525. 10.2144/000112010, 16235564.
33. Nelson PT, Baldwin DA, Kloosterman WP, Kauppinen S, Plasterk RH, Mourelatos Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006, 12:187-191. 10.1261/rna.2258506, 1370897, 16373485.
34. Allawi HT, Dahlberg JE, Olson S, Lund E, Olson M, Ma WP, Takova T, Neri BP, Lya-michev VI. Quantitation of microRNAs using a modified Invader assay. RNA 2004, 10:1153-1161. 10.1261/rna.5250604, 1370605, 15208450.
35. Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: Current status and prospective. Int J Cancer 2007, 120:953-960. 10.1002/ijc.22454, 17163415.
36. Moghimi-Dehkordi B, Safaee A, Ghiasi S, Zali MR. Survival in gastric cancer patients: univariate and multivariate analysis. East Afr J Public Health 2009, 6:41-44.
37. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348. 10.1038/35077213, 11357141.
38. Sánchez CA, Rodríguez E, Varela E, Zapata E, Páez A, Massó FA, Montaño LF, Lóopez-Marure R. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest 2008, 26:698-707.
39. Park WH, Lee YY, Kim ES, Seol JG, Jung CW, Lee CC, Kim BK. Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis. Anticancer Res 1999, 19:3133-3140.
40. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531. 10.1038/nrg1379, 15211354.
41. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
42. Pagliocca A, Wroblewski LE, Ashcroft FJ, Noble PJ, Dockray GJ, Varro A. Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells. Am J Physiol Gastrointest Liver Physiol 2002, 283:292-299.
43. Xie B, He SW, Wang XD. Effect of gastrin on protein kinase C and its subtype in human colon cancer cell line SW480. World J Gastroenterol 2000, 6:304-306.
44. Yen TW, Sandgren EP, Liggitt HD, Palmiter RD, Zhou W, Hinds TR, Grippo PJ, McDonald JM, Robinson LM, Bell RH. The gastrin receptor promotes pancreatic growth in transgenic mice. Pancreas 2002, 24:121-129. 10.1097/00006676-200203000-00002, 11854616.
45. Lefranc F, Chaboteaux C, Belot N, Brotchi J, Salmon I, Kiss R. Determination of RNA expression for cholecystokinin/gastrin receptors (CCKA, CCKB and CCKC) in human tumors of the central and peripheral nervous system. Int J Oncol 2003, 22:213-219.
46. Bläker M, Arrenberg P, Stange I, Schulz M, Burghardt S, Michaelis H, Pace A, Greten H, von Schrenck T, de Weerth A. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT. Regul Pept 2004, 118:111-117.
47. Moody TW, Jensen RT. CI-988 inhibits growth of small cell lung cancer cells. J Pharmacol Exp Ther 2001, 299:1154-1160.
48. Zhou JJ, Chen ML, Zhang QZ, Zao Y, Xie Y. Blocking gastrin CCK-B autocrine loop affects cell proliferation and apoptosis in vitro. Mol Cell Biochem 2010, 343:133-141. 10.1007/s11010-010-0507-5, 20559691.
49. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H, Chau N, Cleary M, Jackson AL, Carleton M, Lim L. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007, 27:2240-2252. 10.1128/MCB.02005-06, 1820501, 17242205.
50. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 2009, 315:1439-1447. 10.1016/j.yexcr.2008.12.010, 19133256.
51. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27:91-105. 10.1016/j.molcel.2007.06.017, 17612493.
52. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008, 68:10094-10104. 10.1158/0008-5472.CAN-08-1569, 2836584, 19074875.
53. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y, Ogawa R, Harata K, Fujii Y. MicroRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009, 34:537-542.